Imophoron

Imophoron developed a new class of synthetic vaccine to tackle emerging infectious diseases. Its novel platform was based a single component of the human Adenovirus that spontaneously formed a superparticle, the ADDomer, demonstrating both thermostability and the ability to deliver vaccine intranasally. While active, the team worked on generating universal vaccine candidates for Chikungunya, Respiratory Syncytical Virus and Covid-19.